Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Lawsuit investigates ADMA Biologics over alleged misleading revenue claims after stock plunge.

Market News
18 May 2026
PRNewsWire
View Source
Bearish
pluang ai news

Rosen Law Firm is investigating ADMA Biologics for allegedly issuing misleading business information that caused its stock to drop 16.6% after a short seller accused the company of inflating revenue through channel stuffing. Investors who bought ADMA securities may join a class action to seek compensation without upfront fees. The law firm, known for its expertise in securities litigation, is preparing to recover losses for shareholders affected by the alleged misconduct.

More News (ADMA)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App